Sufentanil Sublingual Tablet 30 mcg
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Sufentanil Sublingual Tablet 30 mcg, covering 2017-02-13 to 2017-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Acute Pain [Phase 3]